Timothy Romanoski
Family Medicine · Annapolis, MDNPI 1144451584
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Novo Nordisk at 27.8% of the total. Reporting peaked in 2019 at $574 and has fallen 51.2% since, to $280 in 2025.
Across 84 payments — averaging $18.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$422
- Pfizer$193
- AbbVie$153
- AstraZeneca$122
- Amgen$96
- Lilly USA, LLC$93
- plus $436 from 16 others
What the payments were for
- Food & beverage$1,49499%
- Education$221%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $422 |
| Pfizer | 11 | $193 |
| AbbVie(2 entities) | 9 | $153 |
| AstraZeneca | 7 | $122 |
| Amgen | 5 | $96 |
| Lilly USA, LLC | 5 | $93 |
| Merck | 4 | $57 |
| Insmed, Inc. | 2 | $44 |
| Mylan Specialty L.p. | 2 | $41 |
| Sunovion Pharmaceuticals Inc. | 2 | $34 |
| GSK | 2 | $32 |
| Merz North America, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $26 |
| Johnson & Johnson | 2 | $26 |
| Kowa Pharmaceuticals America, Inc. | 2 | $24 |
| Corcept Therapeutics | 1 | $21 |
| Astellas Pharma US Inc | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $18 |
| Fidia Pharma USA Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
How this compares
$1,516 in reported general payments places this provider in the 75th percentile of 1,193 family medicine providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $543 |
| Omeprazole | 13 | $205 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Annapolis
- Karen DonaldsonBaltimore$899K
- Louis JacquesBaltimore$522K
- Michael ObiefuneBaltimore$291K
- Thomas LawrenceBerlin$254K
- Casey ScottCambridge$88K
- Daljeet SalujaBaltimore$63K
- Sanjay SaxenaHagerstown$60K
- Cynthia KleppingerSilver Spring$51K
- Tramaine DavisBowie$43K
- Alkesh PatelColumbia$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.